Business Context and Reporting Period
This Form 8-K Current Report is filed by Bionexus Gene Lab Corp, a company incorporated in Wyoming with principal executive offices in Kuala Lumpur. The report covers the event date of October 1, 2020, with Board approval occurring on October 7, 2020.
Key Financial Metrics
This filing is a current report regarding a change in accounting firm and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Change in Certifying Accountant: Total Asia Associates PLT resigned as the Company's independent registered public accounting firm effective October 1, 2020.
- Successor Firm: JP Centurion & Partners PLT became the new independent registered public accounting firm following a merger of audit operations.
- Audit History: The prior accountant's reports for the years ended December 31, 2019, and 2018 contained no adverse opinions, disclaimers, or qualifications.
- Disagreements: The Company reported no disagreements with the former accountant regarding accounting principles, practices, or audit scope during the relevant periods.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of future risks. The primary disclosure relates to the administrative transition of the audit firm. The Company confirmed that no consultations were held with the new firm regarding accounting principles or potential audit opinions prior to the appointment.
Investor Verification Checklist
- Verify the independence and qualifications of the new auditor, JP Centurion & Partners PLT.
- Review the letter from Total Asia Associates PLT (Exhibit 16.1) to confirm their agreement with the Company's statements regarding the resignation.
- Confirm that the merger of audit operations did not result in any undisclosed disagreements or scope limitations.
- Check subsequent filings for the first financial statements audited by the new firm to ensure continuity in reporting standards.